Does Eli Lilly and Company (LLY) Pay Dividends? Dividend Analysis & Yield
Quick Answer
Yes, Eli Lilly and Company (LLY) pays a regular quarterly cash dividend. As of July 2026, the company pays a quarterly dividend of $1.73 per share, which translates to an annualized dividend of $6.92 per share [6, 8]. At current stock prices, this represents a dividend yield of approximately 0.48% to 0.51% [6, 9]. Eli Lilly has a strong track record of dividend reliability, having paid dividends for decades and raised its payout for 11 consecutive years [8].
Current Stock Price & Valuation
As of mid-2026, Eli Lilly's stock has seen tremendous growth, driven largely by its cardiometabolic and weight-loss drug portfolio (including Zepbound and Mounjaro).
- Stock Price: ~$1,354.00 - $1,428.00 [7, 8]
- Market Capitalization: ~$1.26 Trillion [7]
- Trailing P/E Ratio: The company's earnings have surged, with Q2 2026 net income up 25% year-over-year to $7.09 billion [4].
- Revenue Growth: Q2 2026 revenue grew by an impressive 48% year-over-year [4].
- Earnings Per Share (EPS): Diluted EPS for Q2 2026 was $7.94, up 26% from the prior year [4].
Detailed Analysis
Dividend Yield and Annual Payout
Eli Lilly's current annualized dividend is $6.92 per share, distributed in four quarterly payments of $1.73 [6, 8]. Because of the massive appreciation in LLY's stock price over the last few years, the dividend yield is relatively low, sitting at roughly 0.48% to 0.51% [6, 9]. This is significantly lower than the healthcare sector average of around 1.38% to 1.77% [5, 9], but this low yield is a function of rapid share price appreciation rather than a lack of dividend growth.
Payout Ratio and Safety
A critical metric for dividend safety is the payout ratio, which measures the percentage of earnings paid out as dividends. Eli Lilly's current payout ratio is exceptionally healthy at approximately 21.7% to 22% [5, 8, 9]. This low payout ratio indicates that the dividend is extremely safe (rated 'A' for safety) [8]. It leaves the company with ample free cash flow to reinvest in its pipeline, expand manufacturing capacity (such as its recent $4.5 billion commitment to Indiana manufacturing sites) [4], and continue growing the dividend in the future.
Dividend Growth Rate
Eli Lilly has demonstrated a strong commitment to dividend growth. The company has raised its dividend for 11 consecutive years [8]. Over the past five years, the dividend has grown at an impressive average annual rate of 15.2% [8]. For context, the quarterly dividend was $0.98 in 2022, $1.50 in 2025, and is now $1.73 in 2026 [2, 10].
Bull Case
The bull case for Eli Lilly's dividend centers on its explosive earnings growth and low payout ratio. The company's revenue is growing at nearly 50% year-over-year, fueled by blockbuster drugs like Zepbound, which alone generated $4.9 billion in U.S. revenue in Q2 2026 [4]. With a payout ratio of just 22% [8], LLY has massive headroom to continue its double-digit dividend growth rate (15.2% 5-year CAGR) [8] without straining its balance sheet. Investors buying LLY today are doing so for total return and future yield-on-cost, rather than current yield.
Bear Case
The bear case for income investors is simply the current yield. At ~0.50% [8], LLY does not provide meaningful current income compared to risk-free assets or higher-yielding healthcare peers. Furthermore, the company's massive $1.26 trillion valuation [7] means that any stumbles in clinical trials, regulatory pushback, or pricing pressures on its weight-loss drugs could lead to a sharp contraction in the stock price, wiping out years of dividend income in capital losses.
Key Metrics Summary
| Metric | Value |
|---|---|
| Annual Dividend | $6.92 per share [8] |
| Quarterly Payout | $1.73 per share [6] |
| Dividend Yield | ~0.48% - 0.51% [6, 9] |
| Payout Ratio | ~22% [8, 9] |
| 5-Year Div Growth Rate | 15.2% [8] |
| Consecutive Increases | 11 Years [8] |
| Payment Frequency | Quarterly [6] |
Frequently Asked Questions
When is Eli Lilly's next ex-dividend date?
Eli Lilly's next ex-dividend date is scheduled for August 14, 2026, for its Q3 payment, followed by November 13, 2026, for its Q4 payment [6, 10].
How much of its earnings does LLY pay out as dividends?
Eli Lilly pays out approximately 22% of its trailing 12-month earnings as dividends [8, 9]. This low payout ratio provides a wide margin of safety and room for future increases.
Is Eli Lilly's dividend safe?
Yes, the dividend is considered very safe. With a payout ratio of just 22% [8] and net income growing at 25% year-over-year [4], the company easily covers its dividend obligations while funding heavy capital expenditures.
Why is LLY's dividend yield so low?
The yield is low because the stock price has appreciated massively. While the company has grown its dividend by an average of 15.2% annually over the last five years [8], the stock price has grown much faster (up over 440% in 5 years) [8], mathematically driving the yield down to around 0.50%.
Final Verdict
Eli Lilly and Company (LLY) is a phenomenal dividend growth stock, though it is not suitable for investors seeking high current income. With a yield of roughly 0.50% [8], it lags behind sector averages. However, its incredibly safe payout ratio of 22% [8], combined with a 15.2% five-year dividend growth rate [8] and explosive underlying earnings growth [4], makes it an excellent choice for long-term total return investors who want a rapidly growing income stream. The dividend is highly sustainable and poised for continued double-digit increases in the years ahead.
Ready to Analyze Your Next Investment?
Get a free AI-powered fair value analysis on any stock. See intrinsic value, margin of safety, and institutional-grade risk metrics in seconds. No credit card required.
Want full access to our institutional research tools? Explore Invest Daily Pro.
You're reading about dividend safety. But is YOUR dividend actually safe?
Our AI analyzes payout ratio trends, free cash flow coverage, balance sheet risk, and dividend growth history to give every stock a Fortress Score from 0–100.
Watch: Related Videos
from Invest DailyGet This Analysis in Your Inbox Every Morning
Get our daily market briefing with institutional-grade analysis, key developments, and actionable strategy - delivered before the opening bell.
Essential Reading: Top Investor Guides
Our most comprehensive guides - start here to build a complete investing foundation.
Market Basics
Stock Market Fundamentals: How Markets Work, Reading Charts, and Technical Analysis
Portfolio Strategy
Portfolio Management Masterclass: Asset Allocation, Diversification, and Rebalancing
Retirement
The Complete Retirement Planning Guide: 401(k), IRA, Roth, and FIRE Strategy
Dividend Income
The Ultimate Guide to Dividend Investing: How to Build a Safe Income Portfolio
Valuation
The Complete Guide to Stock Valuation: How to Calculate Intrinsic Value
Financial Statements
How to Read a Balance Sheet Like a Professional Analyst
Monetary Policy
Understanding the Federal Reserve: How Monetary Policy Actually Works
Real Estate
Real Estate Investment Trusts (REITs): A Complete Investor's Guide
Options & Hedging
Options Basics: How to Use Derivatives to Protect Your Portfolio
Investor Psychology
